How new Ibrutinib data may change current practices in CLL

How new Ibrutinib data may change current practices in CLL

moasc

3 years
1,054 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Susan OBrien, M.D., UC Irvine Health discusses how new Ibrutinib data may change current practices in CLL from MOASC Spotlight on ASH 2017
Up Next Autoplay